EE05809B1 - Probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks Clostridium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseks - Google Patents
Probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks Clostridium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseksInfo
- Publication number
- EE05809B1 EE05809B1 EEP201800005A EEP201800005A EE05809B1 EE 05809 B1 EE05809 B1 EE 05809B1 EE P201800005 A EEP201800005 A EE P201800005A EE P201800005 A EEP201800005 A EE P201800005A EE 05809 B1 EE05809 B1 EE 05809B1
- Authority
- EE
- Estonia
- Prior art keywords
- cdad
- lactobacillus plantarum
- microorganism strain
- clostridium difficile
- probiotic microorganism
- Prior art date
Links
- 241000193163 Clostridioides difficile Species 0.000 title abstract 5
- 240000006024 Lactobacillus plantarum Species 0.000 title abstract 3
- 206010012735 Diarrhoea Diseases 0.000 title abstract 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title abstract 2
- 229940072205 lactobacillus plantarum Drugs 0.000 title abstract 2
- 244000005700 microbiome Species 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000006041 probiotic Substances 0.000 title abstract 2
- 230000000529 probiotic effect Effects 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000035784 germination Effects 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract 1
- 229960002675 xylitol Drugs 0.000 abstract 1
- 235000010447 xylitol Nutrition 0.000 abstract 1
- 239000000811 xylitol Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
- A23C19/061—Addition of, or treatment with, microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
- A23C19/061—Addition of, or treatment with, microorganisms
- A23C19/062—Addition of, or treatment with, microorganisms using only lactic acid bacteria, e.g. pediococcus, leconostoc or bifidus sp., or propionic acid bacteria; Treatment with non-specified acidifying bacterial cultures
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/05—Treating milk before coagulation; Separating whey from curd
- A23C19/054—Treating milk before coagulation; Separating whey from curd using additives other than acidifying agents, NaCl, CaCl2, dairy products, proteins, fats, enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Leiutis käsitleb probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379, mida saab kasutada antimikroobse agendina endogeenset ja/või eksogeenset päritolu Clostridium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseks C. difficile eoste germinatsiooni takistamise ja C. difficile vegetatiivsete rakkude paljunemise allasurumise teel. L. plantarum Inducia sobib kasutamiseks samaaegselt antibiootikumiraviga. Tüve L. plantarum Inducia sisaldavad C. difficile vastased kompositsioonid võivad lisaks sisaldada ka ksülitooli.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EEP200800027A EE05341B1 (et) | 2008-05-13 | 2008-05-13 | Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek |
US14/244,284 US20140335066A1 (en) | 2008-05-13 | 2014-04-03 | Lactobacillus plantarum inducia dsm 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against clostridium difficile |
EEP201400038A EE05799B1 (et) | 2014-04-03 | 2014-10-31 | Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks |
Publications (2)
Publication Number | Publication Date |
---|---|
EE201800005A EE201800005A (et) | 2018-07-16 |
EE05809B1 true EE05809B1 (et) | 2018-09-17 |
Family
ID=40957913
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200800027A EE05341B1 (et) | 2008-05-13 | 2008-05-13 | Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek |
EEP201800005A EE05809B1 (et) | 2008-05-13 | 2014-10-31 | Probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks Clostridium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseks |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200800027A EE05341B1 (et) | 2008-05-13 | 2008-05-13 | Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek |
Country Status (10)
Country | Link |
---|---|
US (3) | US20110274789A1 (et) |
EP (2) | EP2288360B1 (et) |
KR (1) | KR101595042B1 (et) |
AT (1) | ATE536879T1 (et) |
DK (2) | DK2288360T3 (et) |
EE (2) | EE05341B1 (et) |
LT (1) | LT3193895T (et) |
PL (1) | PL2288360T3 (et) |
RU (1) | RU2486234C2 (et) |
WO (1) | WO2009138092A1 (et) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE05799B1 (et) * | 2014-04-03 | 2017-10-16 | Biocc Oü | Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks |
EE05341B1 (et) * | 2008-05-13 | 2010-08-16 | O� Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek |
FR2955774A1 (fr) | 2010-02-02 | 2011-08-05 | Aragan | Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation |
ES2402014B1 (es) | 2011-09-07 | 2014-02-27 | Consejo Superior De Investigaciones Científicas (Csic) | Peptido secretado por lactobacillus plantarum con función inmunomoduladora |
RU2606770C2 (ru) * | 2011-12-21 | 2017-01-10 | Компани Жервэ Данон | Штамм lactobacillus mucosae для получения ферментированных пищевых продуктов |
US10688129B2 (en) | 2013-11-26 | 2020-06-23 | Central Biomedia, Inc. | Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile |
SG11201607557WA (en) * | 2014-03-24 | 2016-10-28 | Otsuka Pharma Co Ltd | Novel lactobacillus paracasei strain |
KR102531695B1 (ko) | 2014-11-25 | 2023-05-12 | 디에스엠 아이피 어셋츠 비.브이. | 프로바이오틱으로서 사용하기 위한 락토바실러스, 및 프로바이오틱을 비롯한 제제에 대한 면역 반응을 평가하기 위해 사용되는 혈액 세포 집단 |
RU2567149C1 (ru) * | 2014-12-24 | 2015-11-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | ШТАММ Lactobacillus plantarum, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ КИСЛОМОЛОЧНЫХ ПРОДУКТОВ И ПРОБИОТИЧЕСКИХ ПРЕПАРАТОВ |
KR101675035B1 (ko) * | 2015-07-17 | 2016-11-22 | 주식회사 빙그레 | 락토바실러스 속 균주를 포함하는 생균제 조성물, 동물사료용 첨가제 및 동물사료 조성물 |
US9730969B2 (en) | 2015-11-06 | 2017-08-15 | Mead Johnson Nutrition Company | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain |
KR101794772B1 (ko) * | 2016-06-08 | 2017-12-01 | 강원대학교산학협력단 | 폴리아민 고생산 신균주 바실러스 서브틸리스 ee5 균주 |
US10166262B2 (en) | 2017-04-20 | 2019-01-01 | Ewelina Sosnowska-Turek | Strain of bacteria and composition comprising the same |
KR102486970B1 (ko) * | 2017-09-22 | 2023-01-10 | 주식회사 고바이오랩 | 클로스트리디움 디피실레(Clostridium difficile) 성장 억제효과를 갖는 락토바실러스 균주 |
TWI740101B (zh) * | 2019-02-12 | 2021-09-21 | 大江生醫股份有限公司 | 降膽固醇之益生菌株的用途 |
SK502019A3 (sk) * | 2019-05-15 | 2020-12-02 | Labas Miroslav | Spôsob výroby mlieka a mliečnych doplnkov s unikátnym zložením mastných kyselín obnovovaním komenzálnej prirodzenej mikrobioty |
WO2021207247A1 (en) * | 2020-04-07 | 2021-10-14 | Kalin Health Llc | Spermidine-supplemented food products |
JPWO2021261423A1 (et) * | 2020-06-22 | 2021-12-30 | ||
KR102363975B1 (ko) * | 2020-12-11 | 2022-02-17 | 주식회사 바이오뱅크힐링 | 락토바실러스 플란타룸 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
CN112553115B (zh) * | 2020-12-23 | 2022-09-16 | 南昌大学 | 植物乳杆菌zdy2013在制备缓解肾损伤产品中应用 |
CN113881604B (zh) * | 2021-11-10 | 2023-02-28 | 深圳大学 | 一株植物乳杆菌mm89及其多糖和应用 |
CN115381005B (zh) * | 2022-08-25 | 2023-09-19 | 中国农业科学院饲料研究所 | 植物乳杆菌cicc 6240在消减水产品体内抗生素残留中的应用 |
CN117417847B (zh) * | 2023-08-22 | 2024-03-15 | 大理大学 | 一种大理梭菌及其在制备抗氧化功能性物质中的应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5895758A (en) * | 1997-06-10 | 1999-04-20 | Bio-Energy Systems | Strain of lactobacillus Plantarum |
IT1298918B1 (it) * | 1998-02-20 | 2000-02-07 | Mendes Srl | Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche |
BRPI0113085B1 (pt) * | 2000-08-11 | 2017-09-19 | R. Whitlock David | Preparation to be applied to a surface of an individual understanding ammonia oxidizing bacteria that metabolize transparation, and clothing article |
GB2369777B (en) * | 2000-10-05 | 2004-10-27 | St Ivel Ltd | Food products with antimicrobial lactic acid bacteria |
ITMI20020399A1 (it) * | 2002-02-28 | 2003-08-28 | Ct Sperimentale Del Latte S P | Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici |
DE60323734D1 (de) * | 2002-03-21 | 2008-11-06 | Bifodan As | Lactobacillus-stämme |
RU2247148C2 (ru) * | 2002-05-28 | 2005-02-27 | Пименов Евгений Васильевич | Штамм бактерий lactobacillus plantarum p4, штамм бактерий lactobacillus buchneri p0 и препарат-пробиотик на их основе для коррекции дисбактериозов различной этиологии у людей и животных |
WO2004076615A2 (en) * | 2003-02-27 | 2004-09-10 | Bioneer A/S | Immunomodulating probiotic compounds |
SE527555C2 (sv) * | 2003-04-04 | 2006-04-11 | Probi Ab | Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar |
GB0513556D0 (en) * | 2005-07-01 | 2005-08-10 | Matforsk As | Product |
FR2898014B1 (fr) * | 2006-03-03 | 2008-09-12 | Gervais Danone Sa | Procede de fabrication d'un dessert glace et dessert glace ainsi obtenu |
EE05340B1 (et) * | 2008-05-13 | 2010-08-16 | O� Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tvi Lactobacillus plantarum Tensia DSM 21380 ja selle kasutamine antimikroobse ning verer?hku alandava probiootikuna ning ravimi valmistamiseks ning toiduaine realiseerimisaja pikendamiseks ja toiduaines kontamineerivatemi |
EE05341B1 (et) * | 2008-05-13 | 2010-08-16 | O� Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek |
EP2311473A1 (en) * | 2009-10-09 | 2011-04-20 | AB-Biotics Producciones Industriales De Microbiotas, S.L. | Lactobacillus plantarum strains as probiotics |
-
2008
- 2008-05-13 EE EEP200800027A patent/EE05341B1/et unknown
-
2009
- 2009-05-12 EP EP09745475A patent/EP2288360B1/en active Active
- 2009-05-12 AT AT09745475T patent/ATE536879T1/de active
- 2009-05-12 RU RU2010147343/10A patent/RU2486234C2/ru active
- 2009-05-12 WO PCT/EE2009/000006 patent/WO2009138092A1/en active Application Filing
- 2009-05-12 DK DK09745475.5T patent/DK2288360T3/da active
- 2009-05-12 PL PL09745475T patent/PL2288360T3/pl unknown
- 2009-05-12 US US12/992,862 patent/US20110274789A1/en not_active Abandoned
- 2009-05-12 KR KR1020107028014A patent/KR101595042B1/ko active IP Right Grant
-
2014
- 2014-04-03 US US14/244,284 patent/US20140335066A1/en not_active Abandoned
- 2014-10-31 DK DK14799963.5T patent/DK3193895T3/da active
- 2014-10-31 EP EP14799963.5A patent/EP3193895B1/en active Active
- 2014-10-31 LT LTEP14799963.5T patent/LT3193895T/lt unknown
- 2014-10-31 EE EEP201800005A patent/EE05809B1/et unknown
-
2016
- 2016-04-19 US US15/132,286 patent/US10272122B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
PL2288360T3 (pl) | 2012-06-29 |
DK2288360T3 (da) | 2012-03-19 |
KR20110018898A (ko) | 2011-02-24 |
KR101595042B1 (ko) | 2016-02-17 |
EP3193895A1 (en) | 2017-07-26 |
EE05341B1 (et) | 2010-08-16 |
US20140335066A1 (en) | 2014-11-13 |
EP3193895B1 (en) | 2020-04-15 |
US10272122B2 (en) | 2019-04-30 |
DK3193895T3 (da) | 2020-07-20 |
EE200800027A (et) | 2009-12-15 |
RU2486234C2 (ru) | 2013-06-27 |
EE201800005A (et) | 2018-07-16 |
ATE536879T1 (de) | 2011-12-15 |
LT3193895T (lt) | 2020-07-27 |
RU2010147343A (ru) | 2012-06-20 |
US20160296570A1 (en) | 2016-10-13 |
EP2288360B1 (en) | 2011-12-14 |
US20110274789A1 (en) | 2011-11-10 |
WO2009138092A1 (en) | 2009-11-19 |
EP2288360A1 (en) | 2011-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE05809B1 (et) | Probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks Clostridium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseks | |
EE201400038A (et) | Hüpokolestereemilist ja antimikroobset agenti probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ja Clostridium difficile põhjustatava kõhulahtisuse ennetamisek | |
IN2012DN01638A (et) | ||
WO2010062369A3 (en) | Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth | |
MX339624B (es) | Composiciones mejoradas de celulas y metodos para preparar las mismas. | |
MX2010007338A (es) | Composiciones comestibles. | |
NZ725224A (en) | Compositions comprising a biological control agent and an insecticide | |
WO2009134380A8 (en) | Super fast-acting insulin compositions | |
CA2747703C (en) | Compositions and methods for the treatment or the prevention of infections by e. coli | |
WO2008036374A3 (en) | Allogeneic stem cell transplants in non-conditioned recipients | |
BR122017018225A8 (pt) | Composição fungicida, seus usos, agente fungicida, método para controlar fungos nocivos fitopatogênicos, e semente resistente a fungos nocivos fitopatogênicos | |
NZ700760A (en) | 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors | |
MX2008006546A (es) | Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria. | |
EP3292764A3 (en) | Composition comprising a biological control agent and a fungicide selected from inhibitors of the respiratory chain at complex iii | |
PH12014502654A1 (en) | Composition comprising a biological control agent and a fungicide selected from inhibitors of amino acid or protein biosynthesis, inhibitors of atp production and inhibitors of the cell wall synthesis | |
NZ591040A (en) | Method for treating feed silage for ruminants by treatment with at least two microbes selected from specific Lactobacillus, Enterococcus, Trichosporon strains | |
MX337041B (es) | Cepas y metodos para mejorar la salud y/o desempeño de los rumiantes. | |
MX339951B (es) | Bacillus subtilis aislado de maiz. | |
NO20085170L (no) | Fremgangsmate for utvidelse av lagringsbestandigheten av pulverformige naeringsformuleringer inneholdende levedyktige probiotiske midler | |
WO2009102143A3 (ko) | 김치유래 락토바실러스 플란타룸 bls41 및 그 용도 | |
EP4242294A3 (en) | B. amyloliquefaciens strain and therapeutic use | |
WO2020091179A3 (ko) | 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물 | |
MX2012008930A (es) | Composiciones de etanol. | |
IN2012DN02283A (et) | ||
MX2022001973A (es) | Formulaciones para la prevención o reducción de infecciones por c. difficile. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB1A | Change in the ownership or in the address of the owner |